Sponsor Pipeline

Glaukos Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
10
Recruiting
2
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT05314738
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
overall status: Recruiting → Unknown
Active Trials by Phase
Phase 4
3
Phase 3
1
Phase 2/3
1
Phase 2
3
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06848946 Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone Glaucoma, Open-angle Recruiting
NCT06066645 Travoprost Intraocular Implant + iStent Infinite Glaucoma, Open-Angle Recruiting
NCT07629557 Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal… Keratoconus Recruiting
Phase 3
NCT07495852 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost… Glaucoma Recruiting
Phase 2/3
NCT07075718 Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation… Glaucoma Recruiting
Phase 2
NCT05966493 A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in… Persistent Corneal Epithelial Defect Recruiting
NCT07400952 Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic… Keratoconus Recruiting
NCT07400965 Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis Demodex Blepharitis Recruiting
Not specified
NCT06057051 Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate… Glaucoma Recruiting
NCT07400926 Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg Open Angle Glaucoma (OAG) Recruiting
NCT05127551 Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs… Glaucoma Active, Not Recruiting
Disease Areas
Get alerts when Glaukos Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free